ProfileGDS4718 / 200882_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 93% 97% 95% 94% 96% 96% 94% 93% 95% 95% 94% 96% 96% 96% 95% 94% 95% 96% 96% 95% 94% 94% 95% 94% 97% 93% 95% 93% 96% 96% 97% 92% 93% 97% 98% 96% 94% 93% 97% 94% 95% 96% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.186794
GSM549102patient 115, normal, homogenized [OPG study]9.8113993
GSM549104patient 119, normal, homogenized [OPG study]10.84797
GSM549108patient 138, normal, homogenized [OPG study]10.102795
GSM549119patient 077, normal, homogenized [OPG study]10.001594
GSM549133patient 032, cancer, homogenized [OPG study]10.568496
GSM549139patient 042, cancer, homogenized [OPG study]10.424496
GSM549099patient 107, normal, homogenized [OPG study]9.9898894
GSM549109patient 139, normal, homogenized [OPG study]9.8369793
GSM549110patient 046, normal, homogenized [OPG study]10.302895
GSM549114patient 063, normal, homogenized [OPG study]10.489495
GSM549122patient 082, normal, homogenized [OPG study]9.9662294
GSM549134patient 033, cancer, homogenized [OPG study]10.429396
GSM549136patient 036, cancer, homogenized [OPG study]10.68296
GSM549140patient 044, cancer, homogenized [OPG study]10.376896
GSM549111patient 047, normal, homogenized [OPG study]10.328395
GSM549113patient 057, normal, homogenized [OPG study]10.25394
GSM549132patient 031, cancer, homogenized [OPG study]10.161195
GSM549137patient 038, cancer, homogenized [OPG study]10.321896
GSM549142patient 047, cancer, homogenized [OPG study]9.9981796
GSM549100patient 110, normal, homogenized [OPG study]10.285695
GSM549107patient 135, normal, homogenized [OPG study]10.159894
GSM549115patient 068, normal, homogenized [OPG study]10.280994
GSM549116patient 072, normal, homogenized [OPG study]10.247195
GSM549120patient 078, normal, homogenized [OPG study]10.135894
GSM549131patient 030, cancer, homogenized [OPG study]10.752697
GSM549118patient 074, normal, homogenized [OPG study]9.7885893
GSM549129patient 027, cancer, homogenized [OPG study]10.139195
GSM549123patient 088, normal, homogenized [OPG study]9.7835293
GSM549124patient 006, cancer, homogenized [OPG study]10.184496
GSM549126patient 015, cancer, homogenized [OPG study]10.563996
GSM549128patient 025, cancer, homogenized [OPG study]10.74397
GSM549103patient 117, normal, homogenized [OPG study]9.4295392
GSM549117patient 073, normal, homogenized [OPG study]9.8843193
GSM549138patient 041, cancer, homogenized [OPG study]10.891997
GSM549141patient 045, cancer, homogenized [OPG study]11.206198
GSM549130patient 028, cancer, homogenized [OPG study]10.397396
GSM549101patient 111, normal, homogenized [OPG study]9.8831394
GSM549105patient 128, normal, homogenized [OPG study]9.8272993
GSM549106patient 134, normal, homogenized [OPG study]11.144397
GSM549112patient 048, normal, homogenized [OPG study]10.089694
GSM549125patient 011, cancer, homogenized [OPG study]10.15595
GSM549127patient 024, cancer, homogenized [OPG study]10.23896
GSM549135patient 035, cancer, homogenized [OPG study]10.678796